Achieve Life Sciences | search
Click here to view Achieve Life Sciences news from 60+ newspapers.
Bookmark or Share- Achieve Life Sciences Reaches Agreement with the FDA on Long-Term ...If all of the milestone-driven warrants are exercised in full, Achieve expects to have runway into 2026 and through potential FDA approval. Achieve’s focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.
- Achieve Life Sciences, Inc. (ACHV)Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.
- Press Releases :: Achieve Life Sciences, Inc. (ACHV)Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
- Achieve Life Sciences, Inc. (ACHV) - Stock AnalysisAchieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms.
- Achieve Life Sciences Inc. - MarketWatchAchieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation.
More
